This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Pharma/Biotech GTN Summit
November 18-20, 2024
W Philadelphia HotelPhiladelphia, PA

Michael Christiano
Director, Revenue at Ardelyx
Speaker

Profile

Mr. Christiano has served as Ardelyx Inc’s Director, Revenue Accounting since November 2023. Prior to that, Mr. Christiano served as the Director, Revenue Finance at Biohaven Pharmaceuticals, which was acquired by Pfizer, where he was responsible for overseeing all aspects of the commercial revenue recognition. Earlier in his career, Mr. Christiano was the Director, Finance at Amring Pharmaceuticals (now Nordic Pharma Inc) and Assistant Controller at Amedra Pharmaceuticals (acquired by Impax Labs, now Amneal Pharmaceuticals).

Agenda Sessions

  • Overcoming GTN pain points: Effective techniques and procedures to strengthen processes

    12:00pm

At this event